Skip to main content
. 2014 Aug 22;252(10):1529–1537. doi: 10.1007/s00417-014-2764-6

Fig. 3.

Fig. 3

Comparison of bevacizumab with ranibizumab for anatomical results. Panel a, Change in retinal thickness at fovea at 1 year (microns); Panel b, Presence of intraretinal or subretinal fluid on optical coherence tomography at 1 year; Panel c, Presence of dye leakage on angiogram at 1 year. CI, confidence interval; MD, mean difference; OR, Odds ratio; SD, standard deviation